ORPHANIX
Orphanix is a virtual pharmaceutical start-up that develops drug therapies for neglected and rare diseases called orphan diseases.
ORPHANIX
Social Links:
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Linz, Oberosterreich, Austria
Country:
Austria
Website Url:
http://www.orphanix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Smart App Banner Nextcloud
Investors List
Tech2b Incubator
Tech2b Incubator investment in Seed Round - orphanix
Official Site Inspections
http://www.orphanix.com
- Host name: www183.your-server.de
- IP address: 188.40.2.3
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "orphanix"
About Us - orphanix
By founding orphanix in 2015 we followed our vision of joint forces of . profound R&D know-how, academic expertise in paediatrics and ; the world leading neonatal web community. Our …See details»
orphanix - Crunchbase Company Profile & Funding
Organization. orphanix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Orphanix is a virtual pharmaceutical start-up that …See details»
Orphanix Company Profile 2024: Valuation, Funding & Investors
Orphanix General Information Description. Developer of drugs designed to treat rare diseases. The company formulates drugs for diseases that are not very common among humans, …See details»
Pipeline - orphanix
Retinol x / Orpha007 x. orphanix GmbH covers all key aspects of drug identification, evaluation, research and development. It offers medicinal products solving a high unmet medical need in the paediatric orphan drug space, ready …See details»
Orphanix - Tech2B
Orphanix . Peter Roseggerstrasse 41 . 4910 Ried im Innkreis . Phone: +43 676 9663799. E-mail: [email protected]. Skip Logo Slider. We support Upper Austrian start-ups in all phases of …See details»
Partner Up - orphanix
Orphanix offers novel ready-to-implement products as well as commercialization through licensing and/or co-development. If you are interested in exploring partnership opportunities with …See details»
Orphanet: Orphanix GmbH
Orphanix GmbH. Peter Roseggerstrasse 41. A-4910 RIED IM INNKREIS . AUSTRIA. Phone 1: +43 (0)676 9663799 Contact email: [email protected]. Institution's website Contacts. …See details»
orphanix - Funding, Financials, Valuation & Investors - Crunchbase
Feb 12, 2016 Orphanix is a virtual pharmaceutical start-up that develops drug therapies for neglected and rare diseases called orphan diseases. Search Crunchbase. ... How much …See details»
Orphanix - Drug pipelines, Patents, Clinical trials - Synapse
Nov 2, 2024 Explore Orphanix with its drug pipeline, therapeutic area, technology platform, .See details»
orphanix - Crunchbase
Orphanix is a virtual pharmaceutical start-up that develops drug therapies for neglected and rare diseases called orphan diseases. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Orphanix - Products, Competitors, Financials, Employees, …
Orphanix is a company focused on the development and commercialization of medicinal products for paediatric rare diseases within the pharmaceutical industry. The company specializes in …See details»
Orphanix - Overview, News & Similar companies | ZoomInfo.com
Orphanix combines academic expertise in paediatrics with profound research and development know-how. We identify, develop and commercialise innovative medicinal products to solve …See details»
Orphanix Company Profile - Office Locations, Competitors ... - Craft
Orphanix has 5 employees across 2 locations. See insights on Orphanix including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
EU/3/17/1895 - European Medicines Agency
On 17 July 2017, orphan designation (EU/3/17/1895) was granted by the European Commission to orphanix GmbH, Austria, for retinol for the prevention of retinopathy of prematurity. The …See details»
AOP Orphan: AOP Orphan Pharmaceuticals AG, AOP Orphan IP AG …
May 13, 2019 We are thrilled about the partnership given the successful history and track record of AOP Orphan and AOP Orphan IP AG”, explains Dr. Philipp Heinrich Novak, CEO and …See details»
orphanix - tech2b
Orphanix ist ein virtuelles Pharma Start-up, das Arzneimitteltherapien für vernachlässigte und seltene Erkrankungen, sogenannte “Orphan Diseases” entwickelt. Damit komplementieren wir …See details»
orphanix - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Orphanix is a virtual pharmaceutical start-up that develops drug therapies for neglected and rare diseases called orphan diseases. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Retinol X - AOP Orphan Pharmaceuticals AG/Orphanix
16 Oct 2022 Retinol X is still in phase II trials for Bronchopulmonary dysplasia in Australia (Orphanix pipeline, October 2022) 06 May 2020 Phase-II clinical trials in Bronchopulmonary …See details»
BRIEF—Aspire in-licenses Retinolx from Orphanix
Aug 16, 2022 Anglo-American firm Aspire Pharma has in-licensed Retinolx (vitamin A) from Orphanix, an Austrian biopharma focussed on the development of novel therapeutic orphan …See details»
Orphagenix - Crunchbase Company Profile & Funding
OrphageniX is a biotechnology company that utilizes proprietary single stranded oligonucleotides to treat orphan diseases.See details»